Targanta Submits Marketing Authorization Application for Oritavancin Chiropractic Economics June 3, 2008 Targanta Therapeutics Corporation (Nasdaq: TARG) announced today that it has submitted a Marketing Authorization Related Posts Weathering the unpredictable by recognizing the 3 chiropractic levels of care Glucosamine and constipation: can supplements improve gut health? Large U.K. study connects diet, supplements supporting mental health, combatting anxiety and depression American Chiropractic Association elects leaders, implements governance changes MediHerb® introduces Ashwagandha Forte for patient sleep, stress, immunity support